Before you sell to, join or invest in Fieldstone Bio, Inc.
MentionFox check on Fieldstone Bio, Inc.: only 1 source on file so far (checked 6 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/fieldstone-bio-inc-form-d-25000001
Check Fieldstone Bio, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Fieldstone Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2025-01-31.
Fieldstone Bio, Inc. filed a Form D notice of an exempt securities offering with the SEC on January 31, 2025. The filing reports $5.92M sold. Its industry group is Other Technology. It names Patrick Stone (Executive Officer, Director), Brandon Fields (Director), Calvin Chin (Director) (SEC Form D, January 31, 2025).
Is this your company?
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Sell to companies like Fieldstone Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-01-31 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Fieldstone Bio, Inc.
Free to see. No signup.
Get an email when Fieldstone Bio, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Fieldstone Bio, Inc. raises, hires or launches. No email unless you switch it on.
Watch Fieldstone Bio, Inc. →Get the full cited report on Fieldstone Bio, Inc.
What the filing shows about Fieldstone Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Fieldstone Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Fieldstone Bio, Inc.'s address as 10 Stevens Street #2036, Andover, MA 01810.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Fieldstone Bio, Inc. is a registered filer with the SEC (CIK 2052482) and has filed since 2025-01-31. 1 filing is on record, the latest on 2025-01-31.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Fieldstone Bio, Inc.'s Form D of 2025-01-31 names Patrick Stone, Brandon Fields and Calvin Chin as its officers, directors or promoters.
Its new offerings report $5.92M sold across 1 offering, as its own filings state.
Trailing twelve months. 3852 filings in Other Technology, totalled by week.
Patrick Stone is named as Executive Officer and Director on the Form D that Fieldstone Bio, Inc. filed with the SEC on 31 January 2025, one of 3 people that filing names.
Brandon Fields is named as Director on the Form D that Fieldstone Bio, Inc. filed with the SEC on 31 January 2025, one of 3 people that filing names.
Calvin Chin is named as Director on the Form D that Fieldstone Bio, Inc. filed with the SEC on 31 January 2025, one of 3 people that filing names.
3 people named on the filing — 1 holding an executive role and 2 as directors only.
Named as of the 2025-01-31 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Fieldstone Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Fieldstone Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Fieldstone Bio, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Fieldstone Bio, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Fieldstone Bio, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Fieldstone Bio, Inc.. With no account yet, you sign up free and land on the result.
On these lists: AI and software raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/fieldstone-bio-inc-form-d-25000001